MENU
CDTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cidara Therapeutics (CDTX) Ownership - Who owns Cidara Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
6310 Nancy Ridge Drive
Phone
+1 858 752-6170
Employees
73
Web
https://www.cidara.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
249.52M
P/E Ratio
N/A
Total Cash
127.39M
Projected Growth
N/A
Total Debt
3.94M
Revenue
44.65M
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash/Share
11.65
Total Debt/Equity
N/A
Revenue/Share
8.85 USD as % of share price
Fundamentals
CDTX
Capitalization
250M
P/E Ratio
N/A
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash
127M
Total Cash/Share
11.65
Total Debt
3.94M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.85%
Revenue
44.7M
ROE
N/A
Book Value
116M
P/B Ratio
1.96
Cash Flow
N/A
Earnings
-23.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.54
Current Revenue Per Employee
4136.99
Dividends Per Share - Security
N/A
EBITDA
-127.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.53
Revenue To Assets
-106.94
Shares Held By Institutions
23.6M
Shares Outstanding - Current
10.9M
Total Liabilities
46.7M
Total Volume MTD
N/A
Value
1
Gain YTD
43.640
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs for fungal infection
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
6310 Nancy Ridge Drive
Phone
+1 858 752-6170
Employees
73
Web
https://www.cidara.com